• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

GNE-049

CAS No. 1936421-41-8

GNE-049 ( GNE049 | GNE 049 )

产品货号. M13034 CAS No. 1936421-41-8

GNE-049 (GNE049) 是一种有效的、选择性的、口服的 CBP/p300 bromodomain 抑制剂,生化 IC50 分别为 1.1/2.3 nM。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥4236 有现货
50MG ¥18468 有现货
100MG ¥26487 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    GNE-049
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    GNE-049 (GNE049) 是一种有效的、选择性的、口服的 CBP/p300 bromodomain 抑制剂,生化 IC50 分别为 1.1/2.3 nM。
  • 产品描述
    GNE-049 (GNE049) is a potent, selective, orally available inhibitor of CBP/p300 bromodomain with biochemical IC50 of 1.1/2.3 nM, respectively; displays 3,850-fold selectivity over BRD4; shows excellent potency (12 nM) in a BRET cellular assay and inhibits the expression of MYC with EC50 of 14 nM in MV-4-11 cells; demonstrates significant dose-dependent inhibition of AR signaling and PC proliferation in vitro and in vivo.
  • 体外实验
    GNE-049 is selected for further profiling as it has the best balance ofliver microsomes (LM) stability, selectivity, and cellular potency GNE-049 has excellent potency in the BRET cellular assay and, in an orthogonal measure of the target engagement, GNE-049 is shown to inhibit the expression of MYC (MV4-11 cell line) with an EC50 of 14 nM.
  • 体内实验
    GNE-049 demonstrates acceptable PK in mouse, rat, dog, and monkey. Determination of potency versus a selection of bromodomains revealed that GNE-049 is selective for CBP/P300 and, importantly, quite selective (3820-fold) over BRD4(1). GNE-049 is further evaluated in a rat single dose (30-250 mg/kg QD) toxicokinetic study. Adverse central nervous system (CNS)-related signs (e.g., marked hyperactivity and vocalization) are observed in several of the rats at the 250 mg/kg dose level. Furthermore, at the 250 mg/kg dose level, the ratio of the unbound drug concentration in brain to unbound drug concentration in plasma (Kp,uu) 3 h post dose is determined to be 0.43, indicating that GNE-049 is penetrating into the CNS and potentially resulting in the observed toxicity.
  • 同义词
    GNE049 | GNE 049
  • 通路
    Chromatin/Epigenetic
  • 靶点
    Bromodomain
  • 受体
    Bromodomain
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1936421-41-8
  • 分子量
    510.59
  • 分子式
    C27H32F2N6O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : 100 mg/mL 195.86 mM
  • SMILES
    CC(N1CCC(N(C2COCC2)N=C3N4CCCC5=C4C=C(C(F)F)C(C6=CN(C)N=C6)=C5)=C3C1)=O
  • 化学全称
    1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Jin L, et al. Cancer Res. 2017 Aug 17. pii: canres.0314.2017.
产品手册
关联产品
  • BET-BAY 002

    BET-BAY 002 是一种有效的 BET 溴结构域抑制剂;在多发性骨髓瘤模型中显示出功效。

  • Ischemin sodium

    一种细胞渗透性 CBP 溴结构域抑制剂,Kd 为 19 uM。

  • XDM-CBP

    一种高效、选择性的 CBP/p300 溴结构域抑制剂,Kd 分别为 0.23/0.47 uM。